Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or "the Company"), a global leader in temperature-controlled supply chain solutions ...

Despite challenges like high production costs and uneven regulations, the region is set to become a hub for cutting-edge ...

By strengthening research infrastructure, investing in education, and prioritizing community engagement, this new Center of Excellence will deliver lasting benefits for California, expanding the reach ...

DefEYE’s leadership includes key personnel from the original Verséa Ophthalmics team, ensuring continuity of expertise and relationships in the rapidly evolving eye care market. Celularity has the ...

Please provide your email address to receive an email when new articles are posted on . VG801 is a dual-AAV gene therapy in development for the treatment of Stargardt disease. The therapy is under ...

Spinal cord injury (SCI) remains a major unmet medical challenge, often resulting in permanent paralysis and disability with ...

The Ministry of Health and Welfare and the Regenerative Medicine Advanced Foundation will hold the '2025 RMAF Annual ...

Planarian stem cells can be “independent” and turn into any type of cell without needing a nearby niche, a new study indicates.

GC Cell announced on the 31st that its HER2-targeted allogeneic CAR-NK cell therapy, 'AB-201 (GCC2003),' has received simultaneous approvals for its ...

Biomedical experts and practitioners in North Carolina are developing technology to rebuild skin and repair damaged organs, and they think it can be used to heal injuries on the battlefield. “You have ...

THE Asian Society for Regenerative Medicine (ASRM) proudly announces its 2nd Annual Convention and Workshop, happening at ...